Cooper Companies to acquire Sauflon, CooperVision partners with Turkish university

Article

The Cooper Companies, Inc. announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals for approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 22 percent year-over-year.

Pleasanton, CA-The Cooper Companies, Inc. announced it has entered into definitive agreements to acquire Sauflon Pharmaceuticals for approximately $1.2 billion. Sauflon forecasts revenue of approximately $210 million for its fiscal year ending October 31, 2014, up approximately 22 percent year-over-year.

The transaction is subject to regulatory approval and is anticipated to close prior to the company’s fiscal year end, October 31, 2014.

“We are extremely pleased to announce this acquisition which gives CooperVision the world's most comprehensive portfolio of daily disposable lenses,” says Robert S. Weiss, Cooper's president and chief executive officer. “CooperVision will now be able to offer a multi-tier daily strategy that includes a full suite of silicone hydrogel and hydrogel lenses, including options within all categories-spheres, torics, and multifocals. The daily segment is the fastest growing segment of the soft contact lens market and this transaction positions CooperVision as the premier company in this space.”

In related news, CooperVision recently partnered with Bogazici University’s College of Business in Istanbul, Turkey, to focus on developing its next generation of global leaders. As a component of the company’s Inspirational Leadership Program, a select group of senior leaders spent five days on campus earlier this year, immersing themselves in issues relating to entrepreneurship, governance, national culture and institutions, financial management and growing a high-caliber, emerging market workforce.

Bogazici University is ranked among the world’s top 200 institutions of higher education. Its dynamic faculty is internationally respected and globally connected, and highly able to share experiences and insights regarding the dynamic and sometimes volatile nature of multinational business challenges and opportunities.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.